Global Point of Care Diagnostics/Testing Market Analysis and Forecast Report 2030

$5,000$10,000

Point of Care Diagnostics/Testing Market: By Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Hematology Testing, Cancer/Tumor Marker Testing, Urinalysis Testing, Cholesterol, Drugs-of-Abuse Testing), By End User (Hospitals & Clinics, Diagnostic Centers, Homecare/Self Testing), By Mode of Purchase (OTC, Prescription-based), By Platform (Immunoassays, Molecular Diagnostics, Dipsticks), and Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast to 2030

Description

Global Point of Care Diagnostics/Testing Market Analysis and Forecast Report 2030

Market Overview
CRI has released a report titled
Point of Care Diagnostics/Testing Market – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2031. The market is anticipated to reach USD 36,740.3 million by 2030 at a CAGR of ~11.6% during the forecast period of 2021-2030.

. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market

Point of Care Diagnostics/Testing Market Market: Key Players

Abbott Laboratories (US)
Siemens Healthineers GmbH (Germany)
Chembio Diagnostics, Inc.(US)
Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson Services, Inc. (US)
Becton, Dickinson and Company (US)
Danaher Corporation (US)
PTS Diagnostics (US)
Nova Biomedical (US)
QuidelCorporation (US)
Sekisui Diagnostics (US)
Trinity Biotech (Ireland)
, Ltd.(China)
Instrumentation Laboratory Company (Werfen) (US)
EKF Diagnostics Holdings plc (UK)

Segmentation
Scope of the Report & Segmentation

By Product

Glucose Monitoring
Strips
Meters
Lancets
Cardiometabolic Monitoring
Cardiac Marker Testing Products
Blood Gas/Electrolyte Testing Products
HbA1c Testing Products
Infectious Disease Testing
HIV Testing
Respiratory Infection Testing
Hepatitis Testing
Sexually Transmitted Disease Testing
Others
Coagulation Monitoring
PT/INR Testing
ACT/APTT Testing
Pregnancy & Fertility Testing
Hematology Testing
Cancer/Tumor Marker Testing
Urinalysis Testing
Cholesterol
Drugs-of-Abuse Testing
Others
By End User

Hospitals & Clinics
Diagnostic Centers
Homecare/Self Testing
Others
By Mode of Purchase

OTC Testing Products
Prescription-based testing products
By Platform

Immunoassays
Molecular Diagnostics
Dipsticks
Others

Point of Care Diagnostics/Testing Market Market Dynamics

Point of Care Diagnostics/Testing Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the
Point of Care Diagnostics/Testing Market Market growth?
Which segment accounted for the largest
Point of Care Diagnostics/Testing Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in CRI’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Related Reports: Global Dental Sutures Market Analysis & Forecast 2016-2027

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2.
Point of Care Diagnostics/Testing Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10.
Point of Care Diagnostics/Testing Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11.
Point of Care Diagnostics/Testing Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.
Point of Care Diagnostics/Testing Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile

Abbott Laboratories (US)
Siemens Healthineers GmbH (Germany)
Chembio Diagnostics, Inc.(US)
Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson Services, Inc. (US)
Becton, Dickinson and Company (US)
Danaher Corporation (US)
PTS Diagnostics (US)
Nova Biomedical (US)
QuidelCorporation (US)
Sekisui Diagnostics (US)
Trinity Biotech (Ireland)
, Ltd.(China)
Instrumentation Laboratory Company (Werfen) (US)
EKF Diagnostics Holdings plc (UK)
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Reviews

There are no reviews yet.

Be the first to review “Global Point of Care Diagnostics/Testing Market Analysis and Forecast Report 2030”

[class^="wpforms-"]
[class^="wpforms-"]